The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2014

Filed:

Aug. 13, 2012
Applicants:

Jay W. Pettegrew, Cleveland Heights, OH (US);

Kanagasabai Panchalingam, Monroeville, PA (US);

Inventors:

Jay W. Pettegrew, Cleveland Heights, OH (US);

Kanagasabai Panchalingam, Monroeville, PA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/055 (2006.01); A61K 49/00 (2006.01); A61K 39/00 (2006.01); A61K 39/38 (2006.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); A61K 39/29 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61K 31/22 (2006.01);
U.S. Cl.
CPC ...
A61B 5/0042 (2013.01); A61B 5/14546 (2013.01); A61B 5/4076 (2013.01); A61K 31/22 (2013.01); A61B 5/055 (2013.01); A61B 5/4064 (2013.01);
Abstract

The invention is a method for the differential diagnosis of chronic schizophrenia or chronic alcoholism, by imaging the brain of a subject to detect any or all of the markers phosphocreatine (PCr), N-acetyl aspartate divided by the total creatine signal (NA/Cr), and synaptic phosphodiester (sPDE), and determining any increase or decrease in the presence of such markers compared to normal levels in specified anatomic areas of the brain. The output of such a method, resulting from such imaging, is presented to be viewed by a diagnostician in order to support the differential diagnosis based on the data output.


Find Patent Forward Citations

Loading…